2013
DOI: 10.1111/imj.12225
|View full text |Cite
|
Sign up to set email alerts
|

Heightened clinical suspicion of pulmonary embolism and disregard of the d‐dimer assay: a contemporary trend in an era of increased access to computed tomography pulmonary angiogram?

Abstract: The overall prevalence of PE in subjects undergoing CTPA was significantly lower compared with data in the literature. The authors recommend warranted clinical suspicion of PE should be confirmed by a senior physician prior to placing a patient in the PE work-up pathway. In such patients, the qualitative D-dimer assay should be utilised if PTP is low, and the exclusionary efficiency of the D-dimer will be improved in the setting of higher PE prevalence in this subgroup. Hospitals should audit local PE prevalen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 20 publications
0
8
0
Order By: Relevance
“…[4,9,2125] Data from Australasia is very limited in both quality and quantity, with yields reported from 6% to 14%. [2628]…”
Section: Introductionmentioning
confidence: 99%
“…[4,9,2125] Data from Australasia is very limited in both quality and quantity, with yields reported from 6% to 14%. [2628]…”
Section: Introductionmentioning
confidence: 99%
“…The D-dimer assay stands as a highly sensitive test frequently employed in the evaluation of PE. This test quantifies monoclonal antibodies targeting D-dimer, a byproduct of fibrinolysis, thus reflecting coagulation activity [ 4 ]. Initially, D-dimer levels rise during fibrin clot formation, gradually diminishing as clot organization and adherence commence.…”
Section: Discussionmentioning
confidence: 99%
“…Notably, the D-dimer test has a relatively brief half-life of four to six hours but remains elevated for about seven days post-clot formation. Nevertheless, a negative D-dimer assay is generally deemed reliable, particularly in low- and moderate-risk patients [ 4 ].…”
Section: Discussionmentioning
confidence: 99%
“…In summary, this audit had proven that poor utilization of pretest risk assessment tool d resulted unnecessary use of CTPA that caused harm for some patients. To minimize this problem, we strongly recommend introducing educational interventions such as seminars as well as devising algorithms targeting clinicians who request imaging without compromising patient safety [23,24]. Guidelines such as these are beneficial to clinicians as they aid in overcoming defensive practice and fear of missing the diagnosis [19].…”
Section: Discussionmentioning
confidence: 99%